Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

8 projects found matching your search criteria :

  1. Role of the selected anti-tumor agents transported by electropermeabilization to the drug-sensitive and drug-resistant c...

    Call: PRELUDIUM 8 , Panel: NZ7

    Principal investigator: dr Joanna Barbara Weżgowiec

    Politechnika Wrocławska, Wydział Podstawowych Problemów Techniki

  2. Elaboration of anti-cancer drug implantational delivery system immobilized on polymer matrix

    Call: OPUS 5 , Panel: ST5

    Principal investigator: dr Andrzej Tadeusz Plichta

    Politechnika Warszawska, Wydział Chemiczny

  3. Effect of internal contamination with tritiated water on the innate anti-tumour and inflammatory reactions in radioresis...

    Call: SONATA 1 , Panel: NZ7

    Principal investigator: dr Ewa Małgorzata Nowosielska

    Wojskowy Instytut Higieny i Epidemiologii im. gen. Karola Kaczkowskiego

  4. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  5. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Marta Krawczyk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  6. Single cell multi-omics in defining how specific oncogenic alterations shape the immune microenvironment and responses t...

    Call: OPUS 20 , Panel: NZ4

    Principal investigator: prof. Bożena Kamińska-Kaczmarek

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  7. Delivery of immuno-activators to phagocytic cells in order to obtain an anti-tumor response

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  8. Effect of dendritic cells co-transduced with lentiviral IL-12 and IL-18 gene carriers for activation of anti-tumor respo...

    Call: PRELUDIUM 9 , Panel: NZ4

    Principal investigator: Jagoda Izabela Mierzejewska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk